#ADA2020 Researchers continue to investigate cardioprotective effects of GLP-1 receptor agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists reduce the risk of myocardial infarction, stroke, and similar cardiovascular events, but questions remain about the mechanisms behind the cardioprotection the drugs provide. During a…